MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 
Similar Articles
Chemistry World
April 25, 2008
Rebecca Trager
Environmental Scientists Report Political Interference Hundreds of the US Environmental Protection Agency's scientific staff have experienced political interference in their work, a survey has revealed. mark for My Articles similar articles
Pharmaceutical Executive
January 1, 2009
Jill Wechsler
FDA Turnaround Time Will more resources and new leadership fix FDA, or is a major overhaul in order? mark for My Articles similar articles
Chemistry World
August 7, 2015
Rebecca Trager
US research agencies accused of stifling communication of science US government agencies have put in place obstacles that thwart efforts by science journalists to effectively communicate government science, according to a new report from the Union of Concerned Scientists. mark for My Articles similar articles
Chemistry World
March 6, 2014
Rebecca Trager
Politicians accuse US food agency of illegally monitoring employees Republican leaders on two key congressional committees have concluded in a new report that the US Food and Drug Administration illegally monitored email communications sent by whistleblowers in the agency. mark for My Articles similar articles
Geotimes
May 2006
Constantine & Wilkinson
Translating Science Into Informed Policies To discuss how to get more scientific integrity into policy-making, graduate students at the University of California in Santa Barbara held a panel discussion with the hopes of raising awareness about political interference in government science. mark for My Articles similar articles
Pharmaceutical Executive
October 1, 2006
Patrick Clinton
From the Editor: In Conflict Structured conflicts keep the pharmaceutical industry functioning, and threatens it when they get out of balance. mark for My Articles similar articles
Chemistry World
February 3, 2012
Rebecca Trager
Whistleblowers accuse FDA of spying, persecution The US Food and Drug Administration is being sued by its own scientists and doctors who allege they were spied on and persecuted by the agency for expressing safety concerns about the approval of medical devices. mark for My Articles similar articles
Pharmaceutical Executive
September 1, 2006
Jill Wechsler
Pharm Exec Q&A: A Soft Spot for Whistleblowers FDA's most aggressive critic in Washington is Iowa Senator Charles Grassley. In this exclusive interview, he explains where the agency goes wrong and what he would do to fix it. mark for My Articles similar articles
Pharmaceutical Executive
June 1, 2012
Jill Wechsler
Innovation and Collaboration A rash of "pro-innovative" approaches for testing and regulating medical products offer ways to speed more new products to market. mark for My Articles similar articles
Pharmaceutical Executive
January 1, 2007
Thoughtleader: Peter Pitts. DrugWonks.com Here, the chief voice of a blog hosted by the non-profit Center for Medicine in the Public Interest urges pharma to continuously plug its positions and get politics out of science, and offers some perspective on important regulatory reforms facing the FDA. mark for My Articles similar articles
The Motley Fool
December 5, 2007
Brian Lawler
The FDA Says It Needs a Pep Pill Drugmakers offering new treatments might be discouraged by the FDA's latest report, in which the agency makes its case for additional funding from Congress. mark for My Articles similar articles
Pharmaceutical Executive
June 1, 2007
Clinton & Wechsler
The View From Inside Commissioner Andrew von Eschenbach on drug safety, DTC advertising, FDA's culture, and how the agency plans to bring itself into the age of molecular medicine. mark for My Articles similar articles
Chemistry World
February 16, 2015
Patrick Walter
Poll finds majority of scientists engaging with public Scientists believe that they should take an active role in public policy debates when it comes to science and technology, according to a survey of American Association for the Advancement of Science members. mark for My Articles similar articles
Pharmaceutical Executive
September 1, 2005
Jill Wechsler
Washington Report: Crawford Steps Up As FDA's new commissioner takes the reins, his key challenge is restoring trust in the agency. mark for My Articles similar articles
Science News
May 9, 2009
Charles Niederriter
At Nobel Conference, Scientists And Public Converse The author, a physics professor at Gustavus Adolphus College directs the Nobel Conference, an annual forum where scientists and the public discuss a contemporary scientific topic. mark for My Articles similar articles
Chemistry World
October 22, 2014
Rebecca Trager
Free legal help for embattled US scientists A pro bono network that will provide legal protection for US scientists in government and academia has been launched by the Public Employees for Environmental Responsibility, an environmental group based in Washington, DC. mark for My Articles similar articles
The Motley Fool
March 31, 2008
Brian Lawler
FDA Commish Joins Blogosphere Andrew von Eschenbach, the FDA's chief, starts a weekly blog. mark for My Articles similar articles
Pharmaceutical Executive
April 1, 2007
Patrick Clinton
From the Editor: Taking It Outside FDA Commissioner Andy von Eschenbach said something pretty reasonable, and in return received a blistering, menacing letter from Senator Charles Grassley -- a letter that showed yet again that Grassley just doesn't understand what he's destroying in his campaign against FDA. mark for My Articles similar articles
CIO
March 15, 2006
Allan Holmes
Rx for Risk As it revamps its workflow processes, the FDA is relying on technology to reduce the risk that unsafe substances will get into the market. mark for My Articles similar articles
Information Today
July 28, 2015
Pew Report Delves Into Scientific Attitudes The report, "An Elaboration of AAAS Scientists' Views," explores findings by examining American Association for the Advancement of Science scientists' views on major science-related issues. mark for My Articles similar articles
Reason
November 2005
Tim Cavanaugh
Subsidized Spin The Pentagon is spending $300,000 to send mid-career scientists, researchers, and engineers to a workshop at the television and screen writing school with the hope that some of these scientists will be inspired to produce a screenplay that paints scientists as cool. mark for My Articles similar articles
Pharmaceutical Executive
April 1, 2006
Jill Wechsler
Washington Report: A Warning Trend Washington's new answer to drug safety concerns is more warnings and more disclosure of undigested data. But warnings can go too far. Haven't FDA's critics ever heard the story of the boy who cried wolf? mark for My Articles similar articles
Pharmaceutical Executive
February 1, 2012
Jennifer Ringler
Industry Trees are Falling, But is FDA Around to Hear? Experts weigh in on FDA's long-awaited social media guidelines. mark for My Articles similar articles
The Motley Fool
September 29, 2011
Brian Orelli
Investors Guide to the New PDUFA Changes are in the air for drugmakers and the FDA. mark for My Articles similar articles
Geotimes
July 2004
Suppressing Science in Policy: Sharing Responsibility Recent publicity of the use of science in policy offers an opportune platform from which to reflect not only on the issues raised by politicians and UCS, but also on scientists' own role in widening the gap between science and policy. mark for My Articles similar articles
Geotimes
May 2006
Steven Quane
The Rocket Docket: Legislating Science Out of Public Policy Rhetorically, little resistance exists for U.S. policy-makers to use science fairly and justly in creating the laws of the land. Procedurally, however, that is certainly not the case. mark for My Articles similar articles
The Motley Fool
April 29, 2008
Brian Orelli
Will These Drugs Get FDA Approval? Discovery Laboratories and Adolor are waiting FDA decisions on their drugs next month. mark for My Articles similar articles
Chemistry World
January 3, 2013
Sile Lane
Decisive uncertainty We depend on scientists, often at fraught moments where lives are at stake, being willing to assess the evidence and speak the truth to those in power, as they see it, with all the uncertainties and in the context of what has gone before. mark for My Articles similar articles
Chemistry World
May 2007
Comment: A Matter of Ethics Scientists should embrace a universal ethical code. mark for My Articles similar articles
Pharmaceutical Executive
December 1, 2011
Jill Wechsler
FDA Gets a New Look Agency expansion and globalization promote innovation, collaboration, and organizational changes mark for My Articles similar articles
Pharmaceutical Executive
April 1, 2007
McCook & Daniels
Making the Switch More companies are using Rx-to-OTC switches to extend a brand's life cycle. Prilosec did it. Here, experts dish on how you can do it too. mark for My Articles similar articles
Chemistry World
September 6, 2012
Simon Perks
Rebuilding public trust in Japanese science The aftermath of the Japanese earthquake, the ensuing tsunami and the Fukushima nuclear accident has destroyed the country's trust in science and its role in policy-making. mark for My Articles similar articles
The Motley Fool
April 1, 2011
Travis Hoium
Optimer Pharmaceuticals Shares Popped: What You Need to Know Shares of Optimer Pharmaceuticals jumped 12% today after positive news from the FDA was released. mark for My Articles similar articles
Reason
April 2004
Todd Seavey
Regulation for Dummies A book about the FDA. mark for My Articles similar articles
Pharmaceutical Executive
February 1, 2011
Jill Wechsler
Challenges, Changes, Commitments The Three Cs could be taxing on FDA resources as the new Congress brings stiffer oversight and leadership revisions to the agency mark for My Articles similar articles
The Motley Fool
September 9, 2010
Brian Orelli
Will These Drugs Get Past the FDA This Month? See what the FDA has on its decision calendar for the rest of September. mark for My Articles similar articles
Food Processing
January 2005
David Joy
Regulatory Issues: The FDA agenda for 2005 As in the past, the FDA has a full agenda of food regulatory matters in 2005. So it's not good that the FDA's scientists are demoralized and the agency stands accused of being too friendly with a regulated industry. mark for My Articles similar articles
Pharmaceutical Executive
October 1, 2011
Ansis Helmanis
Lessons from the FDA Front Line Is the research-based industry less productive today than 30 years ago? To former Commissioner Jane Henney, the answer is straightforward. mark for My Articles similar articles
The Motley Fool
October 19, 2010
Brian Orelli
Why the FDA Won't Approve Lorcaserin and Qnexa (Yet) Obesity drugs get their day in front of the agency. mark for My Articles similar articles
IndustryWeek
October 19, 2011
FDA: A Future Innovation Partner? Could the Food and Drug Administration reform itself to help manufacturers create new medical technologies? mark for My Articles similar articles
Pharmaceutical Executive
April 1, 2009
Patrick Clinton
Dear Commissioner... Unsolicited advice for FDA's next leader: Keep it real, fight popular delusions, and somehow, please, defend the agency. mark for My Articles similar articles
Chemistry World
January 3, 2013
Steve Fuller
The public: clients of science? Despite the lip service paid to the virtues of secular democracy, the extent to which the public trusts blindly in research scientists rivals medieval deference to priestly authority. mark for My Articles similar articles
Pharmaceutical Executive
March 1, 2012
Jill Wechsler
When Talk is Not So Cheap FDA and industry are pushing user fees, while they struggle with curbs on communications. mark for My Articles similar articles
Reason
May 2005
Ronald Bailey
Aborting Plan B Barr Pharmaceuticals wants to offer its emergency contraceptive levonorgestrel, marketed as Plan B, over the counter rather than by prescription. The FDA delayed an anticipated decision on the issue indefinitely, adding another chapter to a long and heavily politicized debate. mark for My Articles similar articles
Chemistry World
September 5, 2013
Rebecca Trager
Funding woes lead US scientists to consider moving overseas A new report paints a bleak picture of scientists conducting government funded research in the US. As many as 18% of US scientists questioned for the analysis are considering taking their research to another country. mark for My Articles similar articles
Entrepreneur
March 2005
Stephen Barlas
Just the facts The FDA doesn't want any more lies on dietary supplement labels... Is Sarbanes-Oxley a Class Act?... etc. mark for My Articles similar articles
Chemistry World
June 4, 2009
Rebecca Trager
US regulator rethink on BPA The US Food and Drug Administration (FDA) is revisiting its stance that bisphenol A is safe at current exposure levels. mark for My Articles similar articles
The Motley Fool
May 9, 2007
Brian Lawler
Diagnosing Dendreon Postmortem The FDA issues an approvable letter for Dendreon's top compound. Investors, take note. mark for My Articles similar articles
Pharmaceutical Executive
March 1, 2012
Ron Cohen
FDA's Necessary Dose of Reality There's no fast-acting salve, but there are several steps that can be taken to streamline many of the procedures at FDA. And it begins with leadership. mark for My Articles similar articles
Chemistry World
January 21, 2010
Rebecca Renner
FDA shifts on BPA safety The US Food and Drug Administration has revised its position on the possible developmental health risks from bisphenol A, the controversial and widely used ingredient in hard plastic bottles and food packaging that it declared safe in 2008. mark for My Articles similar articles